97
Participants
Start Date
February 28, 2011
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
chemotherapy
sorafenib 600mg/day capecitabine 1250 mg/m²/day
Institut Jules Bordet, Brussels
Hopital Erasme, Brussels
Cliniques Universitaires Saint Luc, Woluwe-Saint-Lambert
Hopitaux St Joseph, Liège
CHU Ambroise Paré, Mons
Universiteit Ziekenhuis Antwerpen, Antwerp
Entité Jolimontoise, La Louvière
Lead Sponsor
Erasme University Hospital
OTHER
INDC Entité Jolimontoise
UNKNOWN
Centre Hospitalier Chretien
OTHER
Universiteit Antwerpen
OTHER
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER
Hospital Ambroise Paré Paris
OTHER
Jules Bordet Institute
OTHER